$3.66
Value $283M
ALTO and ECL stock compared: price, dividend, valuation and results, from SEC filings.
$3.66
Value $283M
$309.27
Value $87.2B
Alto Ingredients (ALTO) has a market value of $283M and Ecolab (ECL) $87.2B. Over the last year, with dividends, ALTO moved +91.6% and ECL +19.8%. The P/E is 5.7 for ALTO and 41.9 for ECL. Dividend yield: ALTO none, ECL 0.94%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ALTO$283M
ECL$87.2B
ECL is 308 times ALTO
Revenue, 12 months
ALTO$960M
ECL$17.4B
ECL is 18 times ALTO
Net income, 12 months
ALTO$51M
ECL$2.1B
ECL is 41 times ALTO
Operating margin
ALTO2.7%
ECL16.7%
14.0 points apart
ROIC
ALTO6.0%
ECL11.6%
5.6 points apart
P/E
ALTO5.7
ECL41.9
ECL is 7.3 times ALTO
Dividend yield
ALTO0.0%
ECL0.9%
0.9 points apart
5-year return
ALTO-36.1%
ECL+38.8%
74.9 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ALTO-36.1%
ECL+38.8%
| Period | ALTOWith dividends | ECLWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +91.6%Price +91.6% | +19.8%Price +18.5% |
| 3 years since November 13, 2023 | +66.4%+18.5% a yearPrice +66.4% | +78.2%+21.2% a yearPrice +72.8% |
| 5 years since November 12, 2021 | -36.1%-8.6% a yearPrice -36.1% | +38.8%+6.8% a yearPrice +31.2% |
| 10 years since November 15, 2016 | -44.1%-5.7% a yearPrice -44.1% | +201.9%+11.7% a yearPrice +171.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ALTOAlto IngredientsECLEcolab
| Price | $3.66 | $309.27 |
|---|---|---|
| Market value | $283M | $87.2B |
| Enterprise value (EV) | $314M | $99.7B |
| P/E | 5.7 | 41.9 |
| P/E, 5-year median | – | 38.2 |
| P/B | 1.0 | 8.4 |
| EV/EBIT | 12.2 | 34.3 |
| Free cash flow yield | 13.2% | 2.1% |
| Revenue, 12 months | $960M | $17.4B |
|---|---|---|
| Net income, 12 months | $51M | $2.1B |
| Free cash flow, 12 months | $37M | $1.8B |
| Earnings per share, 12 months | $0.65 | $7.35 |
| Revenue growth, year on year | -4.9% | 2.2% |
| Revenue growth a year, past | +0.5%over 5 years | +6.4%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 5.8% | 43.9% |
|---|---|---|
| Operating margin | 2.7% | 16.7% |
| Net margin | 5.3% | 12.0% |
| ROIC | 6.0% | 11.6% |
| ROE | 20.3% | 20.8% |
| Cash | $24M | $722M |
|---|---|---|
| Total debt | $76M | $13.4B |
| Net debt / EBITDA | 0.6 | 3.5 |
| Interest cover | 3.2× | 7.4× |
| Dividend yield | – | 0.9% |
|---|---|---|
| Dividend per share, 12 months | – | $2.92 |
| Dividend growth a year, past | – | +7.2%over 5 years |
| Buyback yield | – | 0.9% |
| Shareholder yield | – | 1.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Ecolab ($87.2B) is about 308.3 times Alto Ingredients ($283M), at today's prices.
Since November 15, 2016, ALTO's price moved -44.1% and ECL's +171.0%. With dividends: ALTO -44.1% (-5.7% a year), ECL +201.9% (+11.7% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Alto Ingredients and 0.94% for Ecolab. Over the last twelve months they paid – and $2.92 per share.
At today's price, the P/E is 5.7 for ALTO and 41.9 for ECL. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 5.3% for Alto Ingredients and 12.0% for Ecolab, and the operating margin 2.7% and 16.7%. Revenue was $960M and $17.4B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.